Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Piramal Pharma LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:543635NSE Symbol: PPLPHARMAP/E(TTM):35.23
ISIN Demat:INE0DK501011Div & Yield %:0.07EPS(TTM):5.41
Book Value(Rs):56.1026791Market Cap ( Cr.):25335.47Face Value(Rs):10
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
INCOME :     
Sales Turnover 5285.714390.113443.223340.422938.81
Excise Duty0.000.000.000.000.00
Net Sales5285.714390.113443.223340.422938.81
Other Income 207.35202.06341.07224.79216.20
Stock Adjustments 84.5761.62-53.3132.66-57.86
Total Income5577.634653.793730.983597.873097.15
EXPENDITURE :     
Raw Materials 2330.532170.461715.171594.171169.91
Power & Fuel Cost131.62112.89107.9483.8368.08
Employee Cost 736.19613.93548.50448.03395.15
Other Manufacturing Expenses 284.35251.57259.29299.83252.74
Selling and Administration Expenses 746.69620.04485.63427.82258.75
Miscellaneous Expenses 100.4664.92182.8159.20117.39
Less: Pre-operative Expenses Capitalised0.000.000.000.000.00
Total Expenditure4329.843833.813299.342912.882262.02
Operating Profit1247.79819.98431.64684.99835.13
Interest 114.56107.10115.8757.294.71
Gross Profit1133.23712.88315.77627.70830.42
Depreciation222.09205.26192.08165.37143.64
Profit Before Tax911.14507.62123.69462.33686.78
Tax199.44112.4838.77110.82104.98
Fringe Benefit tax0.000.000.000.000.00
Deferred Tax20.303.9215.42-16.0310.30
Reported Net Profit691.40391.2269.50367.54571.50
Extraordinary Items 1.243.34-3.14-10.6415.44
Adjusted Net Profit690.16387.8872.64378.18556.06
Adjst. below Net Profit 1.05-3.79-2.5931.70-2.46
P & L Balance brought forward1359.23971.79918.28569.040.00
Statutory Appropriations 0.000.000.000.000.00
Appropriations 14.470.0013.4050.000.00
P & L Balance carried down2037.211359.22971.79918.28569.04
Dividend0.000.000.000.000.00
Preference Dividend0.000.000.000.000.00
Equity Dividend %1.401.100.005.600.00
Earnings Per Share-Unit Curr5.222.960.583.105.75
Earnings Per Share(Adj)-Unit Curr5.222.960.57NANA
Book Value-Unit Curr56.2750.7444.0943.2041.23